Tumour Volume as a Predictor of Survival in Lung Cancer
Author Information
Author(s): MF Jefferson, N Pendleton, EB Faragher, GR Dixon, MW Myskow, MA Horan
Primary Institution: University Hospital of South Manchester
Hypothesis
Does tumour volume significantly predict survival outcomes in patients with non-small-cell lung cancer after surgical resection?
Conclusion
Tumour volume significantly improves the prediction of prognosis for individual NSCLC patients with UICC stage I or II tumours.
Supporting Evidence
- Tumour volume was significantly related to survival time in multivariate analysis.
- The risk of death increased by 23.8% for each doubling of tumour volume in stage I and II patients.
- Overall median survival was 66.0 months for the cohort studied.
Takeaway
The size of the tumor can help doctors predict how long a patient with lung cancer might live after surgery.
Methodology
Cox's proportional hazard analysis was used to assess the prognostic significance of various factors in 669 NSCLC cases treated with surgical resection.
Potential Biases
Selection bias may have occurred as the study only included operable cases.
Limitations
The study may not represent all NSCLC cases as it only included patients selected for surgery.
Participant Demographics
The study included 669 NSCLC patients treated by surgical resection, with a gender distribution of 445 males and 224 females.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 13.2-35.2%
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website